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cific antihypertensive medications. Chronic kidney disease (CKD) was defined as glomerular filtration rate <60 ml· min -1 ·1.73 m -2 , calculated by the Cockcroft-Gault equation, or a requirement for dialysis treatment. A current smoker was defined as one who smoked at the time of CABG or had quit smoking within 1 year prior to the procedure.
Outcomes
Survival data were collected by serial contact with the patients or their families by either telephone interview or letter with questioners sent every 5 years. The details of cause of death were obtained from the medical records of hospitals or by direct contact with private physicians. A survival search was performed by the end of 2000, and a common closing day of September 30, 2000 was used for analysis. Death from myocardial infarction (MI), arrhythmia, congestive heart failure or sudden death was defined as cardiac death.
Risk Variables
Twenty preoperative risk factors were chosen for analysis: MetS, age, gender, 3-vessel disease, left main coronary artery stenosis, percutaneous transluminal coronary angioplasty 0-72 h before operation, unstable angina (UA), previous MI, previous cardiac operation, Canadian Cardiovascular Society angina class 3 or 4, surgical priority, preoperative intra-aortic balloon pumping, left ventricular ejection fraction (LVEF) <40%, hypertension, CKD, chronic obstructive pulmonary disease, aortic calcification, smoker, cerebral and peripheral vascular diseases.
Statistical Analysis
In the comparison of the patients' characteristics, categorical data are tabulated as frequencies and percentages, and continuous variables are expressed as mean ± SD. These data were analyzed using chi-square tests or Student's t-tests. Survival curves of both the MetS and Non-MetS groups were constructed by Kaplan-Meier method and compared by log-rank test. The effect of MetS on long-term mortality after CABG was determined using multivariate Cox proportional-hazard regression analysis. From among the 21 risk factors, covariates with a p-value less than 0.10 were selected for the multivariate analyses. The model was constructed by backward stepwise method first and then by forward stepwise method. The proportional hazard assumption was checked by including the interaction term between MetS and other covariates in this model. Presence of MetS was forced to remain in the multivariate model, and hazard ratios (HRs) and confidence intervals (CIs) were calculated. A p-value <0.05 was considered significant. All statistical analyses were performed using SAS software (SAS Institute, Cary, NC, USA).
Results
All 1,183 consecutive patients who had isolated CABG during the study period completed the follow-up. Among them, 551 (46.6%) met the MetS criteria at the time of Table 1 .
During a mean follow-up period of 10.5±3.6 years, there were 343 (29%) deaths including 106 (9.0%) cardiac deaths. The cumulative survival curves for all-cause mortality grouped by the presence of MetS are shown in Fig 1a: the 12-year survival rate was 68.5% in the MetS group and 74.0% in the non-MetS group. The log-rank test showed that preoperative MetS was associated with a lower survival rate (p=0.006). The cumulative survival curves from cardiac mortality are shown in Fig 1b: In the risk analyses using the Cox proportional-hazard models, a significant interaction was found between MetS and DM. Therefore, further analysis was performed separately for the presence or absence of DM. Among the 909 non-diabetic patients, 537 had MetS and 372 did not. The results of survival analysis of the patients with or without DM are shown in Fig 2. Among the non-diabetic patients, the survival of those with MetS was significantly lower than those without MetS (p=0.036). However, among the diabetic patients, there was no difference between the survival outcomes of the patients with or without MetS (p=0.86). The result from the Cox proportional hazard model for allcause death is shown in Table 2 . All 10 risk variables had an association with long-term death by model selection. MetS at the time of CABG was a risk factor (HR 1.34, 95% CI 1.03-1.74, p=0.028) in the non-diabetic patients; however, among the diabetic patients, the presence of MetS was not associated with long-term outcome.
In the survival analysis for cardiac mortality, the survival of the patients without DM was significantly superior in those without MetS than in those with MetS (Fig 2c; p=0.002). In contrast, survival was similar for patients with DM regardless of MetS (Fig 2d; p=0.60 ). The result from the Cox proportional hazard model for cardiac death is shown in Table 2 . A total of 7 risk variables (MetS, older age, male gender, UA, LVEF <40%, hypertension, and CKD) had an association with long-term death by model selection. MetS was identified as a predictor of cardiac death (HR 2.31, 95% CI 1.36-3.92, p=0.002) among patients without DM, but not among patients with DM (Table 2) .
In addition, patients with DM had higher all-cause mortality when compared with patients without DM (Fig 3a) . With respect to cardiac death, the Kaplan-Meier curve demonstrated that patients with DM had higher mortality than patients without DM (Fig 3b) .
Discussion
MetS is a known risk factor for CAD in the general population, [1] [2] [3] and is a known risk factor for cardiovascular events and non-cardiovascular-related mortalities in patients with CAD. [4] [5] [6] However, MetS was previously unknown in patients with CABG. Although the risk factors of 10-year death have been identified in multiple studies of patients with previous CABG, [6] [7] [8] [9] we are the first to include MetS.
The present study demonstrated that preoperative MetS, together with the other classic risk factors, is an independent predictor of poor long-term outcome after CABG. Furthermore, in comparison with the non-MetS group, the MetS group had more patients with DM, hypertension, and obesity, which were previously considered independent risk factors after CABG. [9] [10] [11] [12] [13] The impact of preoperative MetS in post-CABG patients has not been documented.
It has been shown that MetS is associated with other atherosclerotic diseases, including cerebral stroke and renal dysfunction, 6 but we were unable to find significant differences in the cause of death, other than cardiac death, between patients with and without MetS. The higher total death rate in the MetS group compared with the non-MetS group was related to the higher cardiac mortality in MetS patients than in non-MetS patients.
Risk factors for the development of saphenous vein graft disease include the presence of DM, hyper low-density lipoproteinemia, and hypertension, 14 which in the present study were more frequently observed in patients with MetS. Yilmaz et al reported that MetS increased the risk of saphenous vein graft disease, 15 and may contribute to the progression of saphenous vein graft disease, possibly affecting long-term survival.
Increases in both all-cause and cardiac death became apparent by approximately 10 years after surgery and this effect of MetS on survival after CABG was stronger in non-DM patients than in DM patients. Patients without DM, but with MetS at the time of surgery, are more likely to have late-onset DM. This phenomenon may be appreciated from our finding that the proportions of deaths in patients with and without MetS were similar until approximately 9 years of follow-up, at which time the reduced survival in patients with MetS became apparent (10 years after CABG). Similarly, the higher 12-year survival observed in patients without DM, but with MetS (92%), than in patients with DM, but without MetS (76%), became similar at 15 years (76% and 74%, respectively). The underlying mechanism of MetS is related to insulin resistance, 16 and MetS is a pre-diabetic status. Therefore, it is possible that some non-DM, but MetS, patients developed DM during the follow-up period, because MetS is associated with new onset of DM. 11 These pre-diabetic patients or possible late-developing DM patients may have had further progression of CAD and therefore poor long-term outcomes. In fact, our analysis also showed that the presence of DM was a strong risk factor after CABG, so the prevention of DM is important for improving the long-term prognosis after CABG.
Saphenous vein grafts were frequently used during this study. MetS may contribute to the progression of saphenous vein graft disease, which may also affect long-term survival, as demonstrated by Yilmaz et al who reported that MetS increased the risk of saphenous vein graft disease. 15 Increased saphenous vein disease most likely has an impact on cardiac death.
Study Limitations
Firstly, this was a post hoc investigation. In addition, there are some differences in treatment between this study and the current surgical era; for instance, cardiopulmonary bypass is now used for all CABG, the use of arterial grafts has reduced, and perioperative medications and eligibility for surgical revascularization have changed over time. Another limitation is that the present study identified obesity on the basis of BMI, as waist circumference measurements were not available; however, studies have demonstrated a concordance between a diagnosis of MetS based on BMI and that based on waist circumference. 17, 18 A BMI ≥25 kg/m 2 was selected as the cut-off point for obesity based on the result of a previous study of the relationship between BMI visceral fat area or waist circumference and obesity in a Japanese population. 8 In contrast, if waist circumstance had been used as a definition of obesity for the detection of MetS, more specific results might have been obtained. This study is also limited by a lack of data on the progression of each risk factor in MetS, including new onset of overt DM, hypertension, and dyslipidemia. Furthermore, this study is limited by the homogeneous patient population (almost all were Asian) and the fact that the patients were all treated in the same institution.
Conclusions
This study is the first large observational report to evaluate the relationship between MetS and outcomes 10 years after cardiac revascularization surgery. It demonstrated that preoperative MetS predicted increased all-cause death and cardiac mortality in non-diabetic, but not diabetic, individuals. Our findings suggest that MetS plays important role with regard to secondary prevention after CABG. Thus, components of MetS should continue to be monitored and treated aggressively even after CABG.
